Zecon Berhad Bilan de santé

Santé financière contrôle des critères 2/6

Zecon Berhad possède un total de capitaux propres de MYR415.6M et une dette totale de MYR701.2M, ce qui porte son ratio d'endettement à 168.7%. Son actif total et son passif total sont MYR1.6B et de MYR1.2B. L'EBIT de Zecon Berhad est MYR56.8M ce qui fait que son ratio de couverture des intérêts 1.2. Elle dispose de liquidités et de placements à court terme de MYR36.6M.

Informations clés

168.7%

Ratio d'endettement

RM 701.22m

Dette

Ratio de couverture des intérêts	1.2x
Argent liquide	RM 36.64m
Fonds propres	RM 415.63m
Total du passif	RM 1.21b
Total des actifs	RM 1.62b

Mises à jour récentes de la santé financière

Recent updates

Zecon Berhad (KLSE:ZECON) Use Of Debt Could Be Considered Risky

Aug 06

Here's Why Zecon Berhad (KLSE:ZECON) Is Weighed Down By Its Debt Load

May 07

Zecon Berhad (KLSE:ZECON) Might Have The Makings Of A Multi-Bagger

Feb 13

Here's Why Zecon Berhad (KLSE:ZECON) Is Weighed Down By Its Debt Load

Oct 26

The Returns On Capital At Zecon Berhad (KLSE:ZECON) Don't Inspire Confidence

Jul 06

Is Zecon Berhad (KLSE:ZECON) Using Too Much Debt?

Dec 14

We Like These Underlying Trends At Zecon Berhad (KLSE:ZECON)

Mar 03

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de ZECON ( MYR202.4M ) ne couvrent pas ses passifs à court terme ( MYR1.1B ).

Passif à long terme: Les actifs à court terme de ZECON ( MYR202.4M ) dépassent ses passifs à long terme ( MYR115.0M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de ZECON ( 159.9% ) est considéré comme élevé.

Réduire la dette: Le ratio d'endettement de ZECON a été réduit de 191.8% à 168.7% au cours des 5 dernières années.

Couverture de la dette: La dette de ZECON n'est pas bien couverte par le flux de trésorerie opérationnel ( 5.6% ).

Couverture des intérêts: Les paiements d'intérêts de ZECON sur sa dette ne sont pas bien couverts par l'EBIT ( 1.2 x couverture).

Zecon Berhad Bilan de santé

Santé financière contrôle des critères 2/6

Informations clés

Mises à jour récentes de la santé financière

Zecon Berhad (KLSE:ZECON) Use Of Debt Could Be Considered Risky

Here's Why Zecon Berhad (KLSE:ZECON) Is Weighed Down By Its Debt Load

Here's Why Zecon Berhad (KLSE:ZECON) Is Weighed Down By Its Debt Load

Is Zecon Berhad (KLSE:ZECON) Using Too Much Debt?

Recent updates

Second quarter 2024 earnings released: RM0.003 loss per share (vs RM0.002 loss in 2Q 2023)

Zecon Berhad (KLSE:ZECON) Use Of Debt Could Be Considered Risky

Zecon Berhad Appoints datu Haji Hashim Bin Haji Bojet as Independent and Non Executive Director

New major risk - Revenue and earnings growth

First quarter 2024 earnings released: EPS: RM0.001 (vs RM0.009 in 1Q 2023)

Here's Why Zecon Berhad (KLSE:ZECON) Is Weighed Down By Its Debt Load

Zecon Berhad, Annual General Meeting, Jun 18, 2024

Full year 2023 earnings released: EPS: RM0.014 (vs RM0.029 loss in FY 2022)

Zecon Berhad (KLSE:ZECON) Might Have The Makings Of A Multi-Bagger

New minor risk - Share price stability

Third quarter 2023 earnings released: RM0.056 loss per share (vs RM0.006 profit in 3Q 2022)

Affin Hwang Investment Bank Berhad, Affin Bank Berhad and Bank Pembangunan Malaysia Berhad Provides Court Update Against Zecon Berhad

Here's Why Zecon Berhad (KLSE:ZECON) Is Weighed Down By Its Debt Load

Zecon Berhad Appoints ENCIK MOHAMMED NOOR BIN AHMAD as Independent and Non Executive Member of Audit Committee

Second quarter 2023 earnings released: RM0.002 loss per share (vs RM0.03 loss in 2Q 2022)

New minor risk - Share price stability

First quarter 2023 earnings released: EPS: RM0.009 (vs RM0.017 in 1Q 2022)

Zecon Berhad Announces Resignation of Encik Richard Kiew Jiat Fong as Independent and Non Executive Member of Nomination and Remuneration Committee

Zecon Berhad Appoints Datu Rodziah Binti Morshidi as Independent and Non Executive Director

Full year 2022 earnings released: RM0.028 loss per share (vs RM0.10 loss in FY 2021)

Insufficient new directors

Affin Hwang Investment Bank Berhad, Affin Bank Berhad and Bank Pembangunan Malaysia Berhad Provides Court Update Against Zecon Berhad

Third quarter 2022 earnings released: EPS: RM0.006 (vs RM0.11 loss in 3Q 2021)

Insufficient new directors

Affin Hwang Investment Bank Berhad, Affin Bank Berhad and Bank Pembangunan Malaysia Berhad Announces Announcement on the Status of Default in Payment

Second quarter 2022 earnings released: RM0.03 loss per share (vs RM0.011 profit in 2Q 2021)

The Returns On Capital At Zecon Berhad (KLSE:ZECON) Don't Inspire Confidence

Insufficient new directors

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Insufficient new directors

Now 23% undervalued after recent price drop

Now 21% undervalued after recent price drop

Zecon Berhad Appoints Mohammed Noor Bin Ahmad as Independent and Non-Executive Member of Risk Committee

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Is Zecon Berhad (KLSE:ZECON) Using Too Much Debt?

Insufficient new directors

Full year 2021 earnings released: RM0.026 loss per share (vs RM0.25 profit in FY 2020)

Zecon Berhad Announces Status of Lawsuit for Default in Payment

Third quarter 2021 earnings released: EPS RM0.015 (vs RM0.063 in 3Q 2020)

Zecon Berhad Announces Status of Lawsuit for Default in Payment

We Like These Underlying Trends At Zecon Berhad (KLSE:ZECON)

Second quarter 2021 earnings released: RM0.009 loss per share (vs RM0.035 profit in 2Q 2020)

First quarter 2021 earnings released: RM0.044 loss per share

New 90-day low: RM0.41

New 90-day low: RM0.41

New 90-day low: RM0.45

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines